Neurogene shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Neurogene
Tip: Access up to 7 years of quarterly data
All positions including Neurogene held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurogene by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $103k | 5.9k | 17.33 |
| 2025-06-30 | $89k | 5.9k | 14.95 |
| 2025-03-31 | $71k | 6.1k | 11.71 |
| 2024-12-31 | $138k | 6.1k | 22.86 |
| 2024-09-30 | $254k | 6.1k | 41.96 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors